Six-coordinate oxo-vanadium(V) dimer complex with methoxy bridging: Synthesis, crystal structure, biological activity and molecular docking
暂无分享,去创建一个
[1] A. Akbari,et al. Synthesis, spectral characterization, DFT calculations, antimicrobial activity and molecular docking of 4-bromo-2-((2-hydroxy-5-methylphenylimino)methyl)phenol and its V(V) complex , 2017 .
[2] S. Zabin,et al. Oxo/dioxo-vanadium(V) complexes with Schiff base ligands derived from 4-amino-5-mercapto-3-phenyl-1,2,4-triazole , 2016 .
[3] J. Simpson,et al. Antimicrobial activity of aroylhydrazone-based oxido vanadium(v) complexes: in vitro and in silico studies , 2016 .
[4] R. Baggio,et al. A novel oxido-vanadium(V) Schiff base complex: synthesis, spectral characterization, crystal structure, electrochemical evaluation, and biological activity , 2016, Research on Chemical Intermediates.
[5] M. Dušek,et al. Synthesis, spectral characterization, structural studies, molecular docking and antimicrobial evaluation of new dioxidouranium(VI) complexes incorporating tetradentate N2O2 Schiff base ligands , 2015 .
[6] F. Pavan,et al. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents. , 2014, Journal of inorganic biochemistry.
[7] J. Castro,et al. Synthesis, X-ray crystal structure, DFT calculation and catalytic activity of two new oxido-vanadium(V) complexes containing ONO tridentate Schiff bases , 2014 .
[8] N. Raman,et al. Biosensitive metal chelates from curcumin analogues: DNA unwinding and anti-microbial evaluation , 2014 .
[9] Sean P. Millikan,et al. New polyfunctional imidazo[4,5-C]pyridine motifs: synthesis, crystal studies, docking studies and antimicrobial evaluation. , 2014, European journal of medicinal chemistry.
[10] A. J. Blake,et al. Oxidovanadium(V) complexes containing hydrazone based O,N,O-donor ligands: Synthesis, structure, catalytic properties and theoretical calculations , 2014 .
[11] B. Kalluraya,et al. Synthesis, characterization and molecular docking studies of some new 1,3,4-oxadiazolines bearing 6-methylpyridine moiety for antimicrobial property. , 2013, European journal of medicinal chemistry.
[12] M. Drew,et al. Chemistry of mixed-ligand complexes with variable valence VOz+ (z = 2, 3) incorporating pentadentate hydrazone ligands , 2012 .
[13] M. Drew,et al. Oxidoalkoxidovanadium(V) complexes: Synthesis, characterization and comparison of X-ray crystal structures , 2012 .
[14] H. R. Dash,et al. Oxovanadium(V) complexes incorporating tridentate aroylhydrazoneoximes: Synthesis, characterizations and antibacterial activity , 2012 .
[15] M. Patel,et al. SOD mimic activity, DNA binding and in-vitro antibacterial studies of drug based copper(II) complexes , 2010 .
[16] M. Drew,et al. Synthesis, structure and solution chemistry of quaternary oxovanadium(V) complexes incorporating hydrazone ligands , 2009 .
[17] M. Drew,et al. Chemistry of mixed-ligand methoxy bonded oxidovanadium(V) complexes with a family of hydrazone ligands containing VO3+ core and their substituent controlled methoxy-bridged dimeric forms , 2008 .
[18] M. Kurup,et al. Synthesis, spectral and EPR studies of oxovanadium(IV) complexes incorporating tridentate ONO donor hydrazone ligands: Structural study of one oxovanadium(V) complex , 2008 .
[19] D. Rehder. Bioinorganic Vanadium Chemistry , 2008 .
[20] M. Drew,et al. Synthesis, structure, solution chemistry and the electronic effect of para substituents on the vanadium center in a family of mixed-ligand [VVO(ONO)(ON)] complexes , 2007 .
[21] D. Rehder. Biological and medicinal aspects of vanadium , 2003 .